KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) FCF Margin (2016 - 2026)

Zimmer Biomet Holdings has reported FCF Margin over the past 18 years, most recently at 15.48% for Q1 2026.

  • For Q1 2026, FCF Margin fell 223.0% year-over-year to 15.48%; the TTM value through Mar 2026 reached 17.33%, down 164.0%, while the annual FY2025 figure was 17.89%, 102.0% up from the prior year.
  • FCF Margin for Q1 2026 was 15.48% at Zimmer Biomet Holdings, down from 19.73% in the prior quarter.
  • Over five years, FCF Margin peaked at 27.09% in Q4 2023 and troughed at 9.15% in Q1 2024.
  • A 5-year average of 17.13% and a median of 16.79% in 2022 define the central range for FCF Margin.
  • On a YoY basis, FCF Margin climbed as much as 1719bps in 2023 and fell as far as -973bps in 2023.
  • Year by year, FCF Margin stood at 9.91% in 2022, then surged by 173bps to 27.09% in 2023, then dropped by -17bps to 22.48% in 2024, then decreased by -12bps to 19.73% in 2025, then fell by -22bps to 15.48% in 2026.
  • Business Quant data shows FCF Margin for ZBH at 15.48% in Q1 2026, 19.73% in Q4 2025, and 18.17% in Q3 2025.